中東およびアフリカの分子診断サービス市場
Market Size in USD Billion
CAGR :
% 
USD
5,364.08 Thousand
USD
8,823.38 Thousand
2022
2030
 予測期間 |
2023 –2030 |
 市場規模（基準年） |
USD 5,364.08 Thousand |
 Market Size (Forecast Year) |
USD 8,823.38 Thousand |
 CAGR |
% |
| Major Markets Players |
|
中東およびアフリカの分子診断サービス市場、サービスタイプ別（機器修理サービス、トレーニングサービス、コンプライアンスサービス、校正サービス、メンテナンスサービス、スケーラブル自動化サービス、ターンキーサービス、機器移転サービス、ハードウェアカスタマイズ、パフォーマンス保証サービス、設計および開発サービス、サプライチェーンソリューション、新製品導入サービス、製造サービス、環境および規制サービス、医療管理システム認証および監査、臨床研究サービス、コンサルティングサービス、およびその他のサービス）、テクノロジー（PCR、リアルタイムPCR、次世代シーケンシング、およびその他のテクノロジー）、エンドユーザー（病院、診断センター、学術研究機関、その他）の2030年までの業界動向と予測。
中東およびアフリカの分子診断サービス市場分析と洞察
検査、治療、迅速な診断に対する需要の高まりが、市場全体の成長を後押ししています。分子診断分野への資金の増加も、市場の成長に貢献しています。主要な市場プレーヤーは、さまざまな新しい診断サービスに非常に注力しています。さらに、慢性疾患や感染症の蔓延の増加も、市場の需要増加に貢献しています。
中東およびアフリカの分子診断サービス市場は、市場プレーヤーの増加と市場でのさまざまな高度な分子診断サービスの利用可能性により、予測年度に成長しています。これに伴い、市場での政府と民間の協力の数が増加し、市場の成長をさらに後押ししています。ただし、分子診断ラボのセットアップやその他の機器に関連する高コストは、予測期間中の市場の成長を妨げる可能性があります。
主要な市場プレーヤーによる戦略的取り組み、政府と民間の協力関係の強化、研究開発活動の増加により、市場の成長の機会が生まれています。しかし、政府による厳しい規制と熟練した専門家の不足が、市場の成長に対する主な課題となっています。
中東およびアフリカの分子診断サービス市場は、2022年の5,364.08千米ドルから2030年には8,823.38千米ドルに達し、2023年から2030年の予測期間に6.7%のCAGRで成長すると予想されています。
|
レポートメトリック |
詳細 |
|
予測期間 |
2023年から2030年 |
|
基準年 |
2022 |
|
歴史的な年 |
2021 (2020 - 2016 にカスタマイズ可能) |
|
定量単位 |
収益（千米ドル） |
|
対象セグメント |
サービスタイプ別（機器修理サービス、トレーニングサービス、コンプライアンスサービス、校正サービス、メンテナンスサービス、スケーラブル自動化サービス、ターンキーサービス、機器移転サービス、ハードウェアカスタマイズ、パフォーマンス保証サービス、設計および開発サービス、サプライチェーンソリューション、新製品導入サービス、製造サービス、環境および規制サービス、医療管理システム認証および監査、臨床研究サービス、コンサルティングサービス、その他のサービス）、テクノロジー別（PCR、リアルタイムPCR、次世代シーケンシング、その他のテクノロジー）、エンドユーザー別（病院、診断センター、学術研究機関、その他）。 |
|
対象国 |
南アフリカ、UAE、サウジアラビア、エジプト、イスラエル、クウェート、カタール、オマーン、バーレーン、その他の中東およびアフリカ。 |
|
対象となる市場プレーヤー |
F. Hoffmann-La Roche Ltd、Danaher、BIOMERIEUX、QIAGEN、Thermo Fisher Scientific Inc.、Bio-Rad Laboratories、Inc、Abbott、DiaSorin SpA、Hologic、Inc など。 |
市場の定義
分子診断は、組織や体液中のタンパク質、DNA、RNAなどの分子を研究して病気を特定するプロセスとして知られています。これらの分子診断サービスは、研究室の技術を利用して特定の分子を研究、分析、診断するための戦略として使用されます。これらは、体液中の特定のバイオマーカーの測定、ポリメラーゼ連鎖反応（PCR）に基づく細菌遺伝子の検出、および特定の感染に対する分子反応に特に使用されます。これらのサービスは、より効率的な検査と診断を提供するために使用されます。
分子診断サービスにより、研究者や技術者はより短時間で効率的かつ効果的に成果を出すことができ、アジア太平洋地域の分子診断サービス市場を牽引しています。さらに、臨床診療の可能性を秘めたこれらのサービスは、分子診断の効率を高めるための追加サポートとして利用されており、主要な市場プレーヤーの存在も市場の成長に貢献しています。
中東およびアフリカの分子診断サービス市場の動向
ドライバー
-
慢性疾患および感染症の蔓延の増加
Chronic and infectious diseases are currently the major cause of death among adults in almost all countries. The prevalence of chronic and infectious diseases is increasing, as a result of which people are more dependent on diagnostic labs and centers for disease diagnosis. The rising prevalence has increased the demand for molecular diagnostics services to provide accurate diagnoses, therapies, and test results within less time. Health-damaging behaviors- particularly tobacco use, lack of physical activity, poor eating habits, and excessive alcohol use are major contributors to the rising prevalence of chronic and infectious diseases. These diseases can be diagnosed by several techniques such as immunoassay, molecular techniques, PCR, and gene manipulation techniques among others. Hence, the demand for molecular diagnostic services is increasing to fulfill the patient’s demand for faster diagnosis and treatment.
The occurrence of chronic and infectious diseases is high and the number of molecular tests has also increased for diagnosis and treatment, the demand for products and services will rise eventually. Hence, the rising prevalence of chronic and infectious diseases is driving market growth across the globe.
-
Increasing demand for testing, therapies, and faster diagnostics
The demand for high-priced specialist therapies is more in the present scenario. The awareness among consumers about faster diagnostics is rising and the adoption of analyzer software for molecular diagnostics is increasing at a higher rate. Molecular diagnostics render accurate and effective results and have indispensable applications in disease diagnostics. People are preferring personalized medications that rely on identifying the genetic, epigenomic, and clinical information of the individual.
Furthermore, in recent years patients are shifting to personalized care and treatment and the demand for molecular testing, therapies, and faster diagnostics is increasing which may act as a driving factor for market growth across the globe.
-
Growing funding in the molecular diagnostics segment
Government initiatives, schemes, and funding activities to support and promote innovation and development have increased, as a result, the molecular diagnostics segment is growing rapidly. This segment is an integral part of disease control, hence the funding is rising and scientists are more focused on developing new ideas for disease control and healthy survival. Again chronic disease like cancer has become dominant all over the world and the demand for specialized treatment and the fastest diagnosis is rising.
As the government and public funding are rising to support the molecular diagnostic segment for better innovations and alternatives for faster diagnosis, the market is boosting to a higher extent. Considering the above instances, it can be predicted that growing funding in the molecular diagnostics segment is going to drive the market in near future.
Opportunity
-
政府と民間の協力の拡大
時間のかかる作業や、さまざまな事柄や管理のための非効率的なアプリケーションは、管理スタッフにとって大きな負担であり、エンド ユーザーへの到達が遅いかほとんどありません。したがって、複雑な課題に対処するには、公共部門と民間部門の組織間のコラボレーションが不可欠です。単一の組織では、場合によっては必要なレベルの変化と成果を推進するのに効果が低いためです。コラボレーションは、政府部門と民間部門の両方にとって、新たな機会として機能します。
政府と民間の協力関係の拡大も、診断部門のさらなる経済発展と成長に有益です。さらに、国民の可処分所得の増加は、市場の成長に有利な機会を生み出すのに役立つため、好ましい要因です。
抑制/挑戦
- 熟練した専門家の不足
必要なトレーニングを提供し、専門家を熟練させることにより、さまざまな分子診断サービスからより正確で精度の高い結果が得られます。この課題を克服するには、分子診断において標準化やその他の重要な基準を満たす必要があります。
熟練した専門知識の不足は、ある場所の回復と成長のペースに支障をきたすでしょう。ある場所の失業者は、他の場所では不足しているスキルを持っていることがよくあります。さらに、この分野における急速な技術進歩も専門知識の不足につながります。
分子病理学者やその他の臨床医に対する分子診断検査および機器の実施方法に関する研修が不足しています。研修医およびコンサルタントの臨床医/病理学者の両方が分子診断の教育コースにアクセスでき、基本的な学習教材を提供するための時間と資金が必要であることが重要です。分子診断の知識の実装の改善と、高品質のトレーニング機会へのアクセスの向上が必要です。熟練した専門家が不足すると、迅速な分子診断検査での診断結果が非効率的になり、観察が遅くなります。
熟練した専門家の不足により、研究室の特定の種類の機器や機械の操作が非効率になり、コストのかかる安全上の危険につながり、生産性と収益性の低下に直接つながる可能性があります。したがって、これは作業の品質に影響を与えるだけでなく、財政的制約にもつながります。したがって、これは市場の成長に対する大きな課題の 1 つとなります。
COVID-19後の中東・アフリカ分子診断サービス市場への影響
COVID-19 以降は市場にプラスの影響を与えています。このパンデミックによって多くの人々が影響を受け、診断テストの数は世界中で増加しました。主に、PCR ベースの COVID-19 診断が増加しました。このように、COVID-19 は市場にプラスの影響を与えました。
最近の開発
- 2022年10月、F.ホフマン・ラ・ロシュ社は、CEマークを取得して、セルフテストおよび専門家による使用向けにSARS-CoV-2迅速抗原検査（「2.0」）の次世代ポートフォリオを発表しました。これにより、同社は組織内のこのような革新を通じて消費者に優れたサービスを提供できるようになりました。
中東およびアフリカの分子診断サービス市場の範囲
中東およびアフリカの分子診断サービス市場は、サービスの種類、テクノロジー、エンドユーザーに基づいて、3 つの主要なセグメントに分割されています。これらのセグメントの成長は、業界のわずかな成長セグメントを分析し、コア市場アプリケーションを特定するための戦略的決定を行うための貴重な市場概要と市場洞察をユーザーに提供するのに役立ちます。
サービスタイプ別
- 楽器修理サービス
- トレーニングサービス
- メンテナンスサービス
- 校正サービス
- コンプライアンスサービス
- ターンキーサービス
- スケーラブルな自動化サービス
- ハードウェアのカスタマイズ
- 機器移設サービス
- パフォーマンス保証サービス
- 設計・開発サービス
- サプライチェーンソリューション
- 新製品紹介サービス
- 製造サービス
- 環境および規制サービス
- 医療管理システム認証と監査
- 臨床研究サービス
- コンサルティングサービス
- その他のサービス
サービスタイプに基づいて、市場は、機器修理サービス、トレーニングサービス、メンテナンスサービス、校正サービス、コンプライアンスサービス、ターンキーサービス、スケーラブル自動化サービス、ハードウェアのカスタマイズ、機器移転サービス、パフォーマンス保証サービス、設計および開発サービス、サプライチェーンソリューション、新製品導入サービス、製造サービス、環境および規制サービス、医療管理システムの認証および監査、臨床研究サービス、コンサルティングサービス、およびその他のサービスに分類されます。
テクノロジー別
- PCR
- リアルタイムPCR
- 次世代シーケンシング
- その他のテクノロジー
技術に基づいて、市場は PCR、リアルタイム PCR、次世代シーケンシング、およびその他の技術に分類されます。
エンドユーザー別
- 病院
- 診断センター
- 学術研究機関
- その他
エンドユーザーに基づいて、市場は病院、診断センター、学術研究機関、その他に分類されます。
中東およびアフリカの分子診断サービス市場の地域分析/洞察
中東およびアフリカの分子診断サービス市場が分析され、市場規模の洞察と傾向が国、サービスタイプ、テクノロジー、エンドユーザー別に提供されます。
このレポートで取り上げられている国は、南アフリカ、UAE、サウジアラビア、エジプト、イスラエル、クウェート、カタール、オマーン、バーレーン、その他の中東およびアフリカ諸国です。
南アフリカは、市場シェアと市場収益の面で中東およびアフリカの分子診断サービス市場を支配しており、予測期間中もその優位性を維持し続けるでしょう。
これは、人々の間での意識向上プログラムの実施と、技術の進歩の高まりにより、この市場の成長がさらに促進されるためです。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える個別の市場影響要因と市場規制の変更も提供しています。新規および交換販売、国の人口統計、疾病疫学、輸出入関税などのデータ ポイントは、個々の国の市場シナリオを予測するために使用される主要な指標の一部です。さらに、中東およびアフリカのブランドの存在と入手可能性、地元および国内ブランドとの激しい競争によって直面する課題、販売チャネルの影響を考慮しながら、国別データの予測分析を提供します。
競争環境と中東およびアフリカの分子診断サービス市場シェア分析
中東およびアフリカの分子診断サービス市場の競争状況は、競合他社による詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、中東およびアフリカでのプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などがあります。提供されている上記のデータ ポイントは、市場に対する会社の重点にのみ関連しています。
中東およびアフリカの分子診断サービス市場で活動している主要企業としては、F. Hoffmann-La Roche Ltd、Danaher、BIOMERIEUX、QIAGEN、Thermo Fisher Scientific Inc.、Bio-Rad Laboratories, Inc、Abbott、Hologic, Inc などがあります。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 SERVICE TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES
5.1.2 INCREASING DEMAND FOR TESTING, THERAPIES, AND FASTER DIAGNOSTICS
5.1.3 GROWING FUNDINGS IN MOLECULAR DIAGNOSTICS SEGMENT
5.2 RESTRAINTS
5.2.1 HIGH-COST ASSOCIATED WITH MOLECULAR DIAGNOSTICS LABS SET-UPS AND OTHER INSTRUMENTATIONS
5.2.2 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY KEY PLAYERS
5.3.2 RISING GOVERNMENT AND PRIVATE COLLABORATIONS
5.3.3 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES
5.4 CHALLENGES
5.4.1 STRINGENT REGULATIONS
5.4.2 LACK OF SKILLED PROFESSIONALS
6 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE
6.1 OVERVIEW
6.2 INSTRUMENT REPAIR SERVICES
6.2.1 ON-SITE REPAIR SERVICES
6.2.1 OFF-SITE REPAIR SERVICES
6.3 MAINTENANCE SERVICES
6.4 TRAINING SERVICES
6.4.1 PCR BASED MOLECULAR DIAGNOSTICS
6.4.2 IMMUNOHISTOCHEMISTRY (IHC)
6.4.3 VIRAL LOAD TESTING
6.4.4 INTERPHASE CHROMOSOME PROFILING (ICP)
6.4.5 APPLICATION TRAINING SERVICES
6.5 CALIBRATION SERVICES
6.6 COMPLIANCE SERVICES
6.6.1 IQ/OQ & PM/OQ SERVICES
6.6.2 INSTALLATION SERVICES
6.6.3 VALIDATION SERVICES
6.6.4 OTHER SERVICES
6.7 TURNKEY SERVICES
6.8 SCALABLE AUTOMATION SERVICES
6.8.1 AUTOMATION FOR HIGH-CONTENT SCREENING (HCS)
6.8.2 AUTOMATION FOR HIGH-THROUGHPUT PLATE-BASED ASSAYS
6.8.3 AUTOMATION FOR HIGH-THROUGHPUT CLONE SCREENING
6.9 HARDWARE CUSTOMIZATION
6.1 INSTRUMENT RELOCATION SERVICES
6.10.1 PLATE RECERTIFICATION
6.10.2 FACTORY-APPROVED PARTS
6.10.3 INSTRUMENT PERFORMANCE EVALUATION
6.10.4 OTHER SERVICES
6.11 PERFORMANCE ASSURANCE SERVICES
6.12 DESIGN AND DEVELOPMENT SERVICES
6.13 SUPPLY CHAIN SOLUTIONS
6.14 NEW PRODUCT INTRODUCTION SERVICES
6.15 MANUFACTURING SERVICES
6.16 ENVIRONMENTAL AND REGULATORY SERVICES
6.17 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING
6.18 CLINICAL RESEARCH SERVICES
6.19 CONSULTATIVE SERVICES
6.2 OTHER SERVICES
7 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 REAL TIME PCR
7.2.1 INSTRUMENT REPAIR SERVICES
7.2.2 MAINTENANCE SERVICES
7.2.3 TRAINING SERVICES
7.2.4 CALIBRATION SERVICES
7.2.5 COMPLIANCE SERVICES
7.2.6 TURNKEY SERVICES
7.2.7 SCALABLE AUTOMATION SERVICES
7.2.8 HARDWARE CUSTOMIZATION
7.2.9 INSTRUMENT RELOCATION SERVICES
7.2.10 PERFORMANCE ASSURANCE SERVICES
7.2.11 DESIGN AND DEVELOPMENT SERVICES
7.2.12 SUPPLY CHAIN SOLUTIONS
7.2.13 NEW PRODUCT INTRODUCTION SERVICES
7.2.14 MANUFACTURING SERVICES
7.2.15 ENVIRONMENTAL & REGULATION SERVICES
7.2.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING
7.2.17 CLINICAL RESEARCH SERVICES
7.2.18 CONSULTATIVE SERVICES
7.2.19 OTHER SERVICES
7.3 PCR
7.3.1 INSTRUMENT REPAIR SERVICES
7.3.2 MAINTENANCE SERVICES
7.3.3 TRAINING SERVICES
7.3.4 CALIBRATION SERVICES
7.3.5 COMPLIANCE SERVICES
7.3.6 TURNKEY SERVICES
7.3.7 SCALABLE AUTOMATION SERVICES
7.3.8 HARDWARE CUSTOMIZATION
7.3.9 INSTRUMENT RELOCATION SERVICES
7.3.10 PERFORMANCE ASSURANCE SERVICES
7.3.11 DESIGN AND DEVELOPMENT SERVICES
7.3.12 SUPPLY CHAIN SOLUTIONS
7.3.13 NEW PRODUCT INTRODUCTION SERVICES
7.3.14 MANUFACTURING SERVICES
7.3.15 ENVIRONMENTAL AND REGULATION SERVICES
7.3.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING
7.3.17 CLINICAL RESEARCH SERVICES
7.3.18 CONSULTATIVE SERVICES
7.3.19 OTHER SERVICES
7.4 NEXT GENERATION SEQUENCING
7.4.1 INSTRUMENT REPAIR SERVICES
7.4.2 MAINTENANCE SERVICES
7.4.3 TRAINING SERVICES
7.4.4 CALIBRATION SERVICES
7.4.5 COMPLIANCE SERVICES
7.4.6 TURNKEY SERVICES
7.4.7 SCALABLE AUTOMATION SERVICES
7.4.8 HARDWARE CUSTOMIZATION
7.4.9 INSTRUMENT RELOCATION SERVICES
7.4.10 PERFORMANCE ASSURANCE SERVICES
7.4.11 DESIGN AND DEVELOPMENT SERVICES
7.4.12 SUPPLY CHAIN SOLUTIONS
7.4.13 NEW PRODUCT INTRODUCTION SERVICES
7.4.14 MANUFACTURING SERVICES
7.4.15 ENVIRONMENTAL AND REGULATION SERVICES
7.4.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING
7.4.17 CLINICAL RESEARCH SERVICES
7.4.18 CONSULTATIVE SERVICES
7.4.19 OTHER SERVICES
7.5 OTHER TECHNOLOGIES
8 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.2.1 INSTRUMENT REPAIR SERVICES
8.2.2 MAINTENANCE SERVICES
8.2.3 TRAINING SERVICES
8.2.4 CALIBRATION SERVICES
8.2.5 COMPLIANCE SERVICES
8.2.6 TURNKEY SERVICES
8.2.7 SCALABLE AUTOMATION SERVICES
8.2.8 HARDWARE CUSTOMIZATION
8.2.9 INSTRUMENT RELOCATION SERVICES
8.2.10 PERFORMANCE ASSURANCE SERVICES
8.2.11 DESIGN AND DEVELOPMENT SERVICES
8.2.12 SUPPLY CHAIN SOLUTIONS
8.2.13 NEW PRODUCT INTRODUCTION SERVICES
8.2.14 MANUFACTURING SERVICES
8.2.15 ENVIRONMENTAL AND REGULATORY SERVICES
8.2.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION AND AUDITING
8.2.17 CLINICAL RESEARCH SERVICES
8.2.18 CONSULTATIVE SERVICES
8.2.19 OTHER SERVICES
8.3 DIAGNOSTIC CENTERS
8.3.1 CLINICAL LABORATORIES
8.3.1.1 INSTRUMENT REPAIR SERVICES
8.3.1.2 Maintenance services
8.3.1.3 Training SERVICES
8.3.1.4 CALIBRATION SERVICES
8.3.1.5 COMPLIANCE SERVICES
8.3.1.6 TURNKEY SERVICES
8.3.1.7 SCALABLE AUTOMATION SERVICES
8.3.1.8 HARDWARE CUSTOMIZATION
8.3.1.9 INSTRUMENT RELOCATION SERVICES
8.3.1.10 PERFORMANCE Assurance SERVICES
8.3.1.11 DESIGN and DEVELOPMENT SERVICES
8.3.1.12 SUPPLY CHAIN SOLUTIONS
8.3.1.13 NEW PRODUCT INTRODUCTION SERVICES
8.3.1.14 MANUFACTURING SERVICES
8.3.1.15 ENVIRONMENTAL and REGULATory SERVICES
8.3.1.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION and AUDITING
8.3.1.17 CLINICAL RESEARCH SERVICES
8.3.1.18 CONSULTATIVE SERVICES
8.3.1.19 Other SERVICES
8.3.2 AMBULATORY SURGICAL CENTERS
8.3.2.1 INSTRUMENT REPAIR SERVICES
8.3.2.2 MAINTENANCE SERVICES
8.3.2.3 TRAINING SERVICES
8.3.2.4 CALIBRATION SERVICES
8.3.2.5 COMPLIANCE SERVICES
8.3.2.6 TURNKEY SERVICES
8.3.2.7 SCALABLE AUTOMATION SERVICES
8.3.2.8 HARDWARE CUSTOMIZATION
8.3.2.9 INSTRUMENT RELOCATION SERVICES
8.3.2.10 PERFORMANCE Assurance SERVICES
8.3.2.11 DESIGN and DEVELOPMENT SERVICES
8.3.2.12 SUPPLY CHAIN SOLUTIONS
8.3.2.13 NEW PRODUCT INTRODUCTION SERVICES
8.3.2.14 MANUFACTURING SERVICES
8.3.2.15 ENVIRONMENTAL AND REGULATORY SERVICES
8.3.2.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION and AUDITING
8.3.2.17 CLINICAL RESEARCH SERVICES
8.3.2.18 CONSULTATIVE SERVICES
8.3.2.19 OTHER SERVICES
8.4 ACADEMIC AND RESEARCH INSTITUTES
8.4.1 INSTRUMENT REPAIR SERVICES
8.4.2 MAINTENANCE SERVICES
8.4.3 TRAINING SERVICES
8.4.4 CALIBRATION SERVICES
8.4.5 COMPLIANCE SERVICES
8.4.6 TURNKEY SERVICES
8.4.7 SCALABLE AUTOMATION SERVICES
8.4.8 HARDWARE CUSTOMIZATION
8.4.9 INSTRUMENT RELOCATION SERVICES
8.4.10 PERFORMANCE ASSURANCE SERVICES
8.4.11 DESIGN AND DEVELOPMENT SERVICES
8.4.12 SUPPLY CHAIN SOLUTIONS
8.4.13 NEW PRODUCT INTRODUCTION SERVICES
8.4.14 MANUFACTURING SERVICES
8.4.15 ENVIRONMENTAL AND REGULATORY SERVICES
8.4.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING
8.4.17 CLINICAL RESEARCH SERVICES
8.4.18 CONSULTATIVE SERVICES
8.4.19 OTHER SERVICES
8.5 OTHERS
9 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION
9.1 MIDDLE EAST AND AFRICA
9.1.1 SOUTH AFRICA
9.1.2 SAUDI ARABIA
9.1.3 ISRAEL
9.1.4 EGYPT
9.1.5 U.A.E.
9.1.6 KUWAIT
9.1.7 QATAR
9.1.8 OMAN
9.1.9 BAHRAIN
9.1.10 REST OF MIDDLE EAST AND AFRICA
10 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 F.HOFFMANN-LA ROCHE LTD
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 SERVICE PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 DANAHER
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 BIOMERIEUX
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 SERVICE PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 QIAGEN
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 SERVICE PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 THERMO FISHER SCIENTIFIC
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHARE ANALYSIS
12.5.4 SERVICE PORTFOLIO
12.5.5 RECENT DEVELOPMENT
12.6 ABBOTT
12.6.1 COMPANY SNAPSHOT
12.6.2 REVENUE ANALYSIS
12.6.3 SERVICE PORTFOLIO
12.6.4 RECENT DEVELOPMENT
12.7 BIO-RAD LABORATORIES, INC
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 SERVICE PORTFOLIO
12.7.4 RECENT DEVELOPMENTS
12.8 DIASORIN
12.8.1 COMPANY SNAPSHOT
12.8.2 REVENUE ANALYSIS
12.8.3 SERVICE PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 HOLOGIC, INC
12.9.1 COMPANY SNAPSHOT
12.9.2 REVENUE ANALYSIS
12.9.3 SERVICE PORTFOLIO
12.9.4 RECENT DEVELOPMENT
13 QUESTIONNAIRE
14 RELATED REPORTS
表のリスト
TABLE 1 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 1 MIDDLE EAST & AFRICA INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 2 MIDDLE EAST & AFRICA INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 3 MIDDLE EAST & AFRICA MAINTENANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 4 MIDDLE EAST & AFRICA TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 5 MIDDLE EAST & AFRICA TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 6 MIDDLE EAST & AFRICA CALIBRATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 7 MIDDLE EAST & AFRICA COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 8 MIDDLE EAST & AFRICA COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 9 MIDDLE EAST & AFRICA TURNKEY SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 10 MIDDLE EAST & AFRICA SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 11 MIDDLE EAST & AFRICA SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 12 MIDDLE EAST & AFRICA HARDWARE CUSTOMIZATION IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 13 MIDDLE EAST & AFRICA INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 14 MIDDLE EAST & AFRICA INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 15 MIDDLE EAST & AFRICA PERFORMANCE ASSURANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 16 MIDDLE EAST & AFRICA DESIGN AND DEVELOPMENT SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 17 MIDDLE EAST & AFRICA SUPPLY CHAIN SOLUTIONS SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 18 MIDDLE EAST & AFRICA NEW PRODUCT INTRODUCTION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 19 MIDDLE EAST & AFRICA MANUFACTURING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 20 MIDDLE EAST & AFRICA ENVIRONMENTAL AND REGULATORY SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 21 MIDDLE EAST & AFRICA MEDICAL MANAGEMENT SYSTEMS AND AUDITING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 22 MIDDLE EAST & AFRICA CLINICAL RESEARCH SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 23 MIDDLE EAST & AFRICA CONSULTATIVE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 24 MIDDLE EAST & AFRICA OTHER SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 25 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 26 MIDDLE EAST & AFRICA REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 27 MIDDLE EAST & AFRICA REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 28 MIDDLE EAST & AFRICA PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 29 MIDDLE EAST & AFRICA PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 30 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 31 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 32 MIDDLE EAST & AFRICA OTHER TECHNOLOGIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 33 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 34 MIDDLE EAST & AFRICA HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 35 MIDDLE EAST & AFRICA HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 36 MIDDLE EAST & AFRICA DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 37 MIDDLE EAST & AFRICA DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 38 MIDDLE EAST & AFRICA CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 39 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 40 MIDDLE EAST & AFRICA ACADEMIC AND RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 41 MIDDLE EAST & AFRICA ACADEMIC AND RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 42 MIDDLE EAST & AFRICA OTHERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 43 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 44 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 45 MIDDLE EAST AND AFRICA INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 46 MIDDLE EAST AND AFRICA TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 47 MIDDLE EAST AND AFRICA COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 48 MIDDLE EAST AND AFRICA SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 49 MIDDLE EAST AND AFRICA INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 50 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 51 MIDDLE EAST AND AFRICA REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 52 MIDDLE EAST AND AFRICA PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 53 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 54 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 55 MIDDLE EAST AND AFRICA HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE 2021-2030 (USD THOUSAND)
TABLE 56 MIDDLE EAST AND AFRICA DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 57 MIDDLE EAST AND AFRICA CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 58 MIDDLE EAST AND AFRICA AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 59 MIDDLE EAST AND AFRICA ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 60 SOUTH AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 61 SOUTH AFRICA INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 62 SOUTH AFRICA TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 63 SOUTH AFRICA COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 64 SOUTH AFRICA SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 65 SOUTH AFRICA INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 66 SOUTH AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 67 SOUTH AFRICA REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 68 SOUTH AFRICA PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 69 SOUTH AFRICA NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 70 SOUTH AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 71 SOUTH AFRICA HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 72 SOUTH AFRICA DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 73 SOUTH AFRICA CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 74 SOUTH AFRICA AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 75 SOUTH AFRICA ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 76 SAUDI ARABIA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 77 SAUDI ARABIA INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 78 SAUDI ARABIA TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 79 SAUDI ARABIA COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 80 SAUDI ARABIA SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 81 SAUDI ARABIA INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 82 SAUDI ARABIA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 83 SAUDI ARABIA REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 84 SAUDI ARABIA PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 85 SAUDI ARABIA NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 86 SAUDI ARABIA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 87 SAUDI ARABIA HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 88 SAUDI ARABIA DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 89 SAUDI ARABIA CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 90 SAUDI ARABIA AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 91 SAUDI ARABIA ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 92 ISRAEL MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 93 ISRAEL INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 94 ISRAEL TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 95 ISRAEL COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 96 ISRAEL SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 97 ISRAEL INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 98 ISRAEL MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 99 ISRAEL REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 100 ISRAEL PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 101 ISRAEL NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 102 ISRAEL MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 103 ISRAEL HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 104 ISRAEL DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 105 ISRAEL CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 106 ISRAEL AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 107 ISRAEL ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 108 EGYPT MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 109 EGYPT INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 110 EGYPT TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 111 EGYPT COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 112 EGYPT SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 113 EGYPT INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 114 EGYPT MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 115 EGYPT REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 116 EGYPT PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 117 EGYPT NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 118 EGYPT MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 119 EGYPT HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 120 EGYPT DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 121 EGYPT CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 122 EGYPT AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 123 EGYPT ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 124 U.A.E. MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 125 U.A.E. INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 126 U.A.E. TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 127 U.A.E. COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 128 U.A.E. SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 129 U.A.E. INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 130 U.A.E. MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 131 U.A.E. REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 132 U.A.E. PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 133 U.A.E. NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 134 U.A.E. MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 135 U.A.E. HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 136 U.A.E. DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 137 U.A.E. CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 138 U.A.E. AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 139 U.A.E. ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 140 KUWAIT MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 141 KUWAIT INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 142 KUWAIT TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 143 KUWAIT COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 144 KUWAIT SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 145 KUWAIT INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 146 KUWAIT MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 147 KUWAIT REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 148 KUWAIT PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 149 KUWAIT NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 150 KUWAIT MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 151 KUWAIT HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 152 KUWAIT DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 153 KUWAIT CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 154 KUWAIT AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 155 KUWAIT ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 156 QATAR MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 157 QATAR INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 158 QATAR TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 159 QATAR COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 160 QATAR SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 161 QATAR INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 162 QATAR MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 163 QATAR REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 164 QATAR PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 165 QATAR NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 166 QATAR MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 167 QATAR HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 168 QATAR DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 169 QATAR CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 170 QATAR AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 171 QATAR ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 172 OMAN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 173 OMAN INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 174 OMAN TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 175 OMAN COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 176 OMAN SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 177 OMAN INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 178 OMAN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 179 OMAN REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 180 OMAN PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 181 OMAN NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 182 OMAN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 183 OMAN HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 184 OMAN DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 185 OMAN CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 186 OMAN AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 187 OMAN ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 188 BAHRAIN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 189 BAHRAIN INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 190 BAHRAIN TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 191 BAHRAIN COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 192 BAHRAIN SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 193 BAHRAIN INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 194 BAHRAIN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 195 BAHRAIN REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 196 BAHRAIN PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 197 BAHRAIN NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 198 BAHRAIN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 199 BAHRAIN HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 200 BAHRAIN DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 201 BAHRAIN CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 202 BAHRAIN AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 203 BAHRAIN ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 204 REST OF MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
図表一覧
FIGURE 1 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: SEGMENTATION
FIGURE 11 THE RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 SERVICE TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET
FIGURE 14 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET : BY SERVICE TYPE, 2022
FIGURE 15 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET : BY SERVICE TYPE, 2023-2030 (USD THOUSAND)
FIGURE 16 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET : BY SERVICE TYPE, CAGR (2023-2030)
FIGURE 17 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET : BY SERVICE TYPE, LIFELINE CURVE
FIGURE 18 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY TECHNOLOGY, 2022
FIGURE 19 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY TECHNOLOGY, 2023-2030 (USD THOUSAND)
FIGURE 20 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 21 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET : BY TECHNOLOGY, LIFELINE CURVE
FIGURE 22 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY END USER, 2022
FIGURE 23 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 24 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY END USER, CAGR (2023-2030)
FIGURE 25 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET : BY END USER, LIFELINE CURVE
FIGURE 26 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: SNAPSHOT (2022)
FIGURE 27 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2022)
FIGURE 28 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 29 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 30 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: SERVICE TYPE (2023-2030)
FIGURE 31 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS SERVICES MARKET: COMPANY SHARE 2022 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
